Literature DB >> 2134520

A mathematical model of cancer chemotherapy with an optimal selection of parameters.

R B Martin1, M E Fisher, R F Minchin, K L Teo.   

Abstract

An optimal parameter selection model of cancer chemotherapy is presented which describes the treatment of a tumor over a fixed period of time by the repeated administration of a single drug. The drug is delivered at evenly spaced intervals over the treatment period at doses to be selected by the model. The model constructs a regimen that both minimizes the tumor population at the end of the treatment and satisfies constraints on the drug toxicity and intermediate tumor size. Numerical solutions show that an optimal regimen withholds the bulk of the doses until the end of the treatment period. When a drug used is of either moderate or low effectiveness, an optimal regimen is superior to a schedule that delivers all of the drug at the beginning of the treatment. This study questions whether the current method for the administration of chemotherapy is optimal and suggests that alternative regimens should be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2134520     DOI: 10.1016/0025-5564(90)90005-j

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  4 in total

1.  A spatial model of tumor-host interaction: application of chemotherapy.

Authors:  Peter Hinow; Philip Gerlee; Lisa J McCawley; Vito Quaranta; Madalina Ciobanu; Shizhen Wang; Jason M Graham; Bruce P Ayati; Jonathan Claridge; Kristin R Swanson; Mary Loveless; Alexander R A Anderson
Journal:  Math Biosci Eng       Date:  2009-07       Impact factor: 2.080

2.  Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

Authors:  Ardith W El-Kareh; Rachel E Labes; Timothy W Secomb
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

3.  Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

4.  How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.

Authors:  Elsa Hansen; Robert J Woods; Andrew F Read
Journal:  PLoS Biol       Date:  2017-02-09       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.